Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Nintedanib-[13C,d3] | Nintedanib-[13C,d3] is the labelled analogue of Nintedanib. Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/&beta. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BLP-006061. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Nintedanib Ethanesulfonate (Intedanib Ethanesulfonate) | Nintedanib esylate is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/&beta. Uses: The treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 656247-18-6. Pack Sizes: 500 mg. Product ID: B0084-434827. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Impurities | Nintedanib Impurities are utilized in the development and quality control of pharmaceutical formulations targeting idiopathic pulmonary fibrosis and various cancers. By understanding these impurities, researchers can improve formulation accuracy and safety, ensuring that Nintedanib's therapeutic efficacies in treating fibrotic diseases and malignancies are maximized. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Impurity 6 (Intedanib Impurity 6) | BIBF 1202 is the major in-vivo metabolite of BIBF 1120, which is an oral triple angiokinase inhibitor targeting VEGFR, PDGFR, FGFR. It is a related compound of Intedanib, which is an indolinone derivative that inhibits angiokinase and an antitumor agent. It is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (VEGF) signaling pathway thus inhibition of tumor angiogenesis. Uses: Bibf 1202 is a novel treatment modality in oncology through blockade of the vascular endothelial growth factor (vegf) signaling pathway thus inhibition of tumor angiogenesis. Group: Pharmaceutical. CAS No. 894783-71-2. Pack Sizes: 50 mg. Product ID: B0084-474893. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib Impurity D | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1987887-92-2. Pack Sizes: 100 mg. Product ID: B1421-478184. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Nintedanib (Intedanib) | Nintedanib is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM. It is used for the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC). Group: Pharmaceutical. CAS No. 656247-17-5. Pack Sizes: 500 mg. Product ID: B0084-262244. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Dimethyl 3, 3'- ( ( ( ( (2, 2'- (piperazine-1, 4-diyl)bis (acetyl))bis (methylazanediyl))bis (4, 1-phenylene))bis (azanediyl))bis (phenylmethanylylidene)) (3Z, 3'E)-bis (2-oxoindoline-6-carboxylate) | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 2410284-90-9. Pack Sizes: 1 mg. Product ID: B2694-478193. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| methyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate | An impurity of Nintedanib, which is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/66 nM. Group: Pharmaceutical. CAS No. 1160293-25-3. Pack Sizes: 100 mg. Product ID: B2694-338804. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Methyl 1-Acetyl-2-oxoindoline-6-carboxylate | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 676326-36-6. Pack Sizes: 100 mg. Product ID: B1421-184191. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-Methyl-2-(4-methyl-1-piperazinyl)-N-(4-nitrophenyl)acetamide | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1139453-98-7. Pack Sizes: 100 mg. Product ID: B1421-258623. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 1038972-16-5. Pack Sizes: 100 mg. Product ID: B1421-284921. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| N-methyl-N-(4-nitrophenyl)-2-(piperazin-1-yl)acetamide hydrochloride | An impurity of Nintedanib, a receptor tyrosine kinase (RTK) inhibitor that binds to vascular endothelial growth factor receptor, fibroblast growth factor receptor and platelet derived growth factor receptor. Nintedanib is used as a medication for the treatment of idiopathic pulmonary fibrosis. Group: Pharmaceutical. CAS No. 2037385-84-3. Pack Sizes: 100 mg. Product ID: B1421-284922. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
